Job Description
Responsibilities
* Build, manage and develop relationships with target urologists, uro‑oncologists and MDT leads across approximately 8 private specialist centres nationally.
* Secure formulary inclusion, prescriber engagement and patient access pathways within each target account.
* Navigate private hospital procurement, pharmacy and governance processes to enable product availability at launch.
* Identify and resolve access barriers at account level — including PMI prior authorisation requirements, pharmacy stocking and clinical governance approvals.
* Maintain accurate and current account plans for each target centre with clear access milestones, stakeholder maps and activity records.
* Support the Portfolio Lead in insurer engagement — providing field intelligence on insurer coverage decisions, prior authorisation outcomes and patient funding challenges.
* Act as the field interface between prescribing urologists and insurer medical teams where clinical justification or appeals processes are required.
* Gather and report real‑world coverage data to inform the ongoing insurer access strategy.
* Track and report account‑level sales activity, patient starts, insurer coverage outcomes and access milestones.
* Contribute to quarterly business reviews with accurate field intelligence, account‑level analysis and market insight.
* Manage territory budget (meetings, materials, travel) within agreed parameters and compliance requirements.
* Identify, develop and maintain relationships with key opinion leaders in private urology and uro‑oncology.
* Support clinical education activities, advisory boards and congress engagement in partnership with the MSL.
* Provide field‑based intelligence on clinical sentiment, competitive activity and evolving treatment pathways.
Qualifications
* Significant experience in a KAM or specialist sales role within oncology, haematology or a high‑value specialty therapy area.
* Proven track record of navigating private market access — PMI reimbursement, private hospital networks or high‑cost therapy commissioning pathways.
* Experience working with high‑cost, low‑volume specialty products where access complexity is the primary commercial challenge.
* Strong commercial and financial acumen — able to articulate budget impact arguments and value propositions to clinical and non‑clinical stakeholders.
* Self‑starter with the ability to operate independently in a lean team without traditional sales infrastructure.
* Excellent relationship management skills — credible and confident with senior clinicians, medical directors and insurer personnel.
* Full UK driving licence.
* Direct experience in bladder cancer, urological cancers or intravesical therapy — existing relationships with UK private urology centres an advantage.
* Experience in CAR‑T, cell and gene therapy or other ATMP commercial environments.
* Experience launching a new product in the UK private market from pre‑launch through to established access.
* Existing network across London private oncology/urology (Royal Marsden, HCA, LOC/Harley Street, The Christie).
This Role Offers
* The opportunity to be the commercial lead on the UK private market launch of a first‑in‑class intravesical gene therapy — a genuinely career‑defining assignment.
* A focused, high‑value account universe — quality over quantity, strategic over transactional.
* Close working relationship with a senior commercial team and direct exposure to launch strategy.
* Real autonomy and ownership in a lean, entrepreneurial environment.
#J-18808-Ljbffr